Histochemical Study of Allergic Inflammation in Conjunctiva From Ovalbumin Sensitized Rabbits after Ocular or Nasal Challenge
Rocio Batle, Miguel Vinuesa, MD, PhD, Norberto Bassan, MD, Adriel Martinez, Florencia Giacomozzi, Soledad Chaparro, MD, Valentin Torres, and Florencia Acebal, MD. Catedra Histologia, Facultad de Ciencias Medicas, UNR, Laboratorio Inmunohistoquimica, Rosario, Argentina. Background: We previously demonstrated that subcutaneous sensitization with ovalbumin (OVA) induce generation of specific IgE antibodies and quantitative modifications in immune cells populations from different mucosal sites in rabbit. The aim of the study is characterization of eosinophil infiltration in conjunctival mucosa from OVA sensitized and ocular and nasal challenged rabbits. Methods: Animals were divided into 4 groups: G1 (n ¼ 9): normal control; G2 (n ¼ 10): subcutaneous sensitized with OVA; G3 (n ¼ 10): subcutaneous sensitized and conjunctival challenged with OVA; G4 (n ¼ 9): subcutaneous sensitized and nasal challenged with OVA. Four hours after challenge animals were sacrificed and obtained samples were processed for histochemistry with cromotrope 2R for eosinophil detection. Cells were counted in 200 high power fields per group. Results: Data were expressed as positive cells per high power field. Conjunctival mucosa: G1: 2.3; G2: 3.4; G3: 12.2; G4: 3.3 (G3 vs G1, G2 y G4 P , 0.001). Specific anti-OVA-IgE levels were evaluated by positive passive cutaneous anaphylaxis test (PCA) at 160 fold dilutions. Conclusions: We observed an increase in the number of eosinophils-positive cells after local challenge in conjunctiva as compared to normal controls and sensitized and nasal challenged animals. We conclude that systemic sensitization with soluble antigen and conjunctival challenge induces modifications in number of eosinophil populations in conjunctiva but not in nasal challenged rabbits.
Prevalence of Allergic Conjunctivitis in Childhood
Marcos Geraldini, MD, Herberto Jose Chong Neto, MD, PhD, Carlos Antonio Riedi, MD, PhD, and Nelson Rosario, MD, PhD. Allergy and Immunology, Federal University of Paraná, Curitiba, Brazil. Background: The prevalence of allergic conjunctivitis (AC) has not been established. Estimates suggest that ocular allergies affect 15 to 20% of the worldwide population yet most epidemiological studies encompasses nasal and ocular allergy symptoms together and have not been specific with respect to AC. The aim of this study was to verify the prevalence of ocular allergy symptoms in adolescents. Methods: Adolescents were selected from a sample of schools and selfcompleted in classrooms a previously validated questionnaire on symptoms of AC. AC was considered when more than 3 episodes of ocular itching were reported in the past 12 months. Related symptoms as tearing, photophobia, foreign body sensation, impact on daily activities, and diagnosis of allergic conjunctivitis were analyzed. Results: Questionnaires from 3120 adolescents (mean 13.3 6 1.1 years) were analyzed. Ocular itching in the past 12 months occurred in 1,592 (51%). The most frequent associated symptom was tearing (74%) followed by photophobia (50.1%) and foreign body sensation (37.1%). The prevalence of allergic conjunctivitis was 20.7% affecting more females (56.1% vs 45.9%; P , 0.01). Moderate and severe interference in daily activities were reported by 66% and 21%, respectively. Diagnosis of AC was reported by 47% of them. Conclusions: Symptoms of ocular allergy are common and cause great impact on daily activities in adolescents. Accessing risk factors and the allergic status of these patients should be the focus of future epidemiological studies on AC. 2 Allergy, Policlinica Geral do Rio de Janeiro, Rio de Janeiro, Brazil. Background: Keratoconjunctivitis is a severe form of ocular allergy, difficult to control and with poor prognosis. The purpose of this study was to verify the clinical efficacy of humanized monoclonal antibody omalizumab treatment in children with this condition. Methods: Report of 2 cases of children with severe vernal keratoconjunctivitis poorly controlled by the conventional therapeutic scheme that were submitted to treatment with Omalizumab.The disease was scored according to the severity by ophthalmologic evaluation (amount of viscous mucus, giant papillae .1 mm, aspect of cornea/keratitis) and graduation of allergic symptons (itching, tearing, photophobia), before and after the last subcutaneous administration of Omalizumab.Evaluation by Parents/ guardians using the same score, regarding to itchy eyes, runny eyes and photophobia, after Omalizumab application, was also requested. Results: Case 1: MPOS (7 years) with vernal keratoconjunctivitis and atopic dermatitis since childhood, both with progressive severity. Recalcitrant ocular itching and photophobia, in addition had other atopic conditions such as mild asthma, rhinitis and egg allergy. Total IgE ¼ 1323 IU/mL. Ocular manifestations poorly controlled with topical use of antihistamines, cromolyn, tacrolimus and cyclosporine. The use of topical corticosteroids was frequent, but resulted in brief improvement.Case 2: HCS (6 years) with vernal keratoconjunctivitis since 3 years age, and mild asthma and moderate persistent rhinitis. Continued use of topical tacrolimus 0.03% showed an initial improvement, but subsequent relapses resulted in frequent use of systemic prednisolone and eye drops antibiotics to control symptoms. Total IgE ¼ 1530 IU/mL.After the second Omalizumab application, good or excellent improvement in ocular symptoms of both children was observed by allergists and parents. Ophthalmologic evaluation showed moderate improvement in the amount of slime and little or no improvement in the structural changes of the eye (cornea and appearance of giant papillae). Conclusions: There are few reports about the use of Omalizumab in allergic keratoconjunctivitis. Our work points to the need for further research in this area as the Anti-IgE may become a promising therapy for this difficult to control condition.
